Transaction DateRecipientSharesTypePriceValue
30th October 2020Patrick Mercer71Payment by withholding$1.78$126.38
30th September 2020Patrick Mercer72Payment by withholding$1.96$141.12
3rd September 2020Patrick Mercer15,000Grant/award etc.$0.00
3rd September 2020David Bruce28,000Grant/award etc.$0.00
30th August 2020Patrick Mercer71Payment by withholding$2.12$150.52
14th August 2020Ken Ludlum6,470Open or private sale$20.42$132,117.40
14th August 2020Ken Ludlum13,530Open or private sale$20.05$271,276.50
30th July 2020Patrick Mercer71Payment by withholding$2.11$149.81
16th July 2020Maria Sainz4,122Grant/award etc.$0.00
1st July 2020David Bruce5,378Payment by withholding$2.12$11,401.36
Iridex Corporation
Iridex Corporation logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 9/10.

IRIDEX Corp. engages in developing, manufacturing, and marketing medical systems. Its products include lasers, laser delivery and glaucoma devices, retinal surgical instruments, veterinary, and ENT. The company was founded by Eduardo Arias, Theodore A. Boutacoff, David M. Buzawa and James L. Donovan in February 1989.

Ticker: IRIX
Sector: Healthcare
Industry: Medical Devices
SEC Central Index Key (CIK): 1006045
Employees: 114
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags